Belvedere Trading’s GE HealthCare GEHC Stock Holding History

Belvedere Trading’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-300	Closed	-$24.6K	–	957
2023 Q1	$24.6K	Buy	+300	New	+$21.4K	﹤0.01%	683

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Belvedere Trading's GEHC Position: Q1 2025 in Review

Belvedere Trading sold out of GE HealthCare (GEHC) in Q1 2025, closing a stake of 4,768 shares — an estimated $373K sold.

Belvedere Trading first reported a position in GEHC in Q4 2024 and held it in 1 quarter. The position peaked at $373K in Q4 2024. 1,367 funds tracked by Wall St. Rank hold GEHC as of Q1 2025.

Belvedere Trading reported no remaining GE HealthCare position as of Q1 2025 after selling out during the quarter.
Belvedere Trading sold 4,768 GE HealthCare shares in Q1 2025, an estimated $373K.
Belvedere Trading first reported a position in GE HealthCare in Q4 2024 and held it in 1 quarter.
Belvedere Trading's GE HealthCare position peaked at $373K in Q4 2024.
1,367 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2025.

Based on Belvedere Trading's 13F filing for Q1 2025, filed 9 May 2025.